美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=PROMETHAZINE
符合检索条件的记录共138
14 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称PROMETHAZINE HYDROCHLORIDE PLAIN
申请号008381产品号003
活性成分PROMETHAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径SYRUP;ORAL规格25MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ANI PHARMACEUTICALS INC
2药品名称PROMETHAZINE HYDROCHLORIDE PLAIN
申请号008381产品号004
活性成分PROMETHAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径SYRUP;ORAL规格6.25MG/5ML
治疗等效代码参比药物
批准日期1984/04/18申请机构ANI PHARMACEUTICALS INC
3药品名称PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
申请号011265产品号002
活性成分DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径SYRUP;ORAL规格15MG/5ML;6.25MG/5ML
治疗等效代码参比药物
批准日期1984/04/02申请机构ANI PHARMACEUTICALS INC
4药品名称PROMETHAZINE HYDROCHLORIDE
申请号040026产品号001
活性成分PROMETHAZINE HYDROCHLORIDE市场状态处方药
剂型或给药途径SYRUP;ORAL规格6.25MG/5ML
治疗等效代码AA参比药物
批准日期1998/09/25申请机构HI TECH PHARMACAL CO INC
5药品名称PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
申请号040027产品号001
活性成分DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE市场状态处方药
剂型或给药途径SYRUP;ORAL规格15MG/5ML;6.25MG/5ML
治疗等效代码AA参比药物
批准日期1996/07/31申请机构HI TECH PHARMACAL CO INC
6药品名称PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
申请号040151产品号001
活性成分CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE市场状态处方药
剂型或给药途径SYRUP;ORAL规格10MG/5ML;6.25MG/5ML
治疗等效代码AA参比药物
批准日期1997/08/26申请机构HI TECH PHARMACAL CO INC
7药品名称PROMETHAZINE HYDROCHLORIDE
申请号040372产品号001
活性成分PROMETHAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格25MG/ML
治疗等效代码参比药物
批准日期2000/06/08申请机构HOSPIRA INC
8药品名称PROMETHAZINE HYDROCHLORIDE
申请号040372产品号002
活性成分PROMETHAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格50MG/ML
治疗等效代码参比药物
批准日期2000/06/08申请机构HOSPIRA INC
9药品名称PROMETHAZINE HYDROCHLORIDE
申请号040428产品号001
活性成分PROMETHAZINE HYDROCHLORIDE市场状态处方药
剂型或给药途径SUPPOSITORY;RECTAL规格25MG
治疗等效代码AB参比药物
批准日期2002/02/05申请机构G AND W LABORATORIES INC
10药品名称PROMETHAZINE HYDROCHLORIDE
申请号040428产品号002
活性成分PROMETHAZINE HYDROCHLORIDE市场状态处方药
剂型或给药途径SUPPOSITORY;RECTAL规格12.5MG
治疗等效代码AB参比药物
批准日期2003/03/31申请机构G AND W LABORATORIES INC